Treatment of familial pancreatic cancer and its precursors
β Scribed by Ralph H. Hruban; Marcia I. Canto; Constance Griffin; Scott E. Kern; Alison P. Klein; Dan Laheru; Charles J. Yeo
- Book ID
- 107558378
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 401 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1092-8472
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Based on several caseβcontrol studies, it has been estimated that familial aggregation and genetic susceptibility play a role in up to 10% of patients with pancreatic cancer, although conclusive epidemiologic data are still lacking. Therefore, we evaluated the prevalence of familial pan
Germline CDKN2A mutations have been observed in approximately 20 percent of familial melanoma kindreds from North America, Europe and Australasia. There is also an increased risk of pancreatic cancer in a subset of families with mutations, however, the precise relationship between the CDKN2A gene an